Cover Image

Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression

Oestrogen receptor beta (ERβ) and epidermal growth factor receptor (EGFR) pathway can synergistically promote the proliferation, invasion, and metastasis of non-small-cell lung cancer (NSCLC) cells. ERβ has five subtypes, and the selective splicing of exon 8 in ERβ5 transcription translational phase...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuquan Bai (Author), Wulin Shen (Author), Li Zhang (Author), Zetian Yang (Author), Lecai Xiong (Author), Hexiao Tang (Author), Jinping Zhao (Author)
Format:	Book
Published:	Taylor & Francis Group, 2018-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC
by: Hexiao Tang, et al.
Published: (2018)

Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer
by: Hexiao Tang, et al.
Published: (2018)

Overexpression of Androgen, Oestrogen and Progesterone Receptors in Skin Lesions of Becker's Naevus
by: Ping Sheng, et al.
Published: (2018)

Rhein promotes the proliferation of keratinocytes by targeting oestrogen receptors for skin ulcer treatment
by: Ning Xu, et al.
Published: (2022)

The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer
by: Ashwaq Al Olayan, et al.
Published: (2012)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O'Leary, et al.
Published: (2020)

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Giuliano Palumbo, et al.
Published: (2020)

Epidermal growth factor receptor mutations in adenocarcinoma lung: Comparison of techniques for mutation detection
by: Saumya Shukla, et al.
Published: (2022)

The deep infiltrating endometriosis tissue has lower T-cadherin, E-cadherin, progesterone receptor and oestrogen receptor than endometrioma tissue
by: Ismail Biyik, et al.
Published: (2021)

The role of oestrogen and oestrogen-calcium axis in endometrial carcinoma
by: Jingyi Zhou, et al.
Published: (2024)

Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
by: Sviatoslav Chekhun, et al.
Published: (2023)

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18-21 mutations
by: Nikolova Dafina, et al.
Published: (2022)

Epidermal growth factor receptor: Role in human cancer
by: Prashanth Rajaram, et al.
Published: (2017)

Modulation of Pathological Pain by Epidermal Growth Factor Receptor
by: Jazlyn P. Borges, et al.
Published: (2021)

Mucin Production Correlates with Dual Expression of Epidermal Growth Factor Receptor and Its Ligand the Epidermal Growth Factor in Non-Small Cell Lung Cancer
by: Rancés Blanco, et al.
Published: (2017)

Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma
by: Chan Shen, et al.
Published: (2022)

Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes
by: Xin Yin, et al.
Published: (2022)

Possible Association Between Melanoma Arising from Congenital Naevus and Oestrogen or Progesterone Receptor Expression: Clinicopathological Analysis
by: Chiho Sumitomo, et al.
Published: (2023)

Transcriptional effects of inhibiting epidermal growth factor receptor in keratinocytes
by: Alix Gazel, et al.
Published: (2013)

Nuclear epidermal growth factor receptor as a therapeutic target
by: Benjamin Atwell, et al.
Published: (2023)

Leser-Trelat sign: Eruptive seborrheic keratoses and primary lung adenocarcinomas with an epidermal growth factor receptor mutation
by: August Mathien, BS, et al.
Published: (2023)

Evaluation of Epidermal Growth Factor Receptor Gene Mutations in an Iranian Population with Non-Small Cell Lung Carcinoma
by: Hamzeh Salmani, et al.
Published: (2022)

Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
by: Zhang H
Published: (2016)

Epidermal growth factor receptor and anaplastic lymphoma kinase mutation in adenocarcinoma lung: Their incidence and correlation with histologic patterns
by: Pankaj Gupta, et al.
Published: (2019)

Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis in Adenocarcinoma of Lung, the First Report from Iran
by: Sahand Mohammadzadeh, et al.
Published: (2019)

Assessment of Myometrial Concentrations of Oestrogen and Progesterone Receptors in the Lower Uterine Segment of Full-Term Pregnancies in Presence or Absence of Labour
by: Joana Soares de Arruda, et al.
Published: (2013)

Membranous Insulin-like Growth Factor-1 Receptor (IGF1R) Expression Is Predictive of Poor Prognosis in Patients with Epidermal Growth Factor Receptor ()-Mutant Lung Adenocarcinoma
by: Eunhyang Park, et al.
Published: (2015)

Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
by: Sathishbabu Paranthaman, et al.
Published: (2020)

Retinoic Acid Receptor β Expression in Oral Precancer Progression
by: Prof Shaleen Chandra, et al.
Published: (2023)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
by: Bara A. Shraim, et al.
Published: (2021)

Expression of oestrogen receptor alpha (ERα) in oral lichen planus - A precancerous inflammatory disease in middle-aged females
by: Abhishek Jana, et al.
Published: (2023)

Multiple Routes to Oestrogen Antagonism
by: Hilary R. Glover, et al.
Published: (2010)

Cost of disease progression among US patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
by: Clara Lam, et al.
Published: (2024)

Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients
by: Ji Su Lee, et al.
Published: (2024)

The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells
by: Susanne Hafner, et al.
Published: (2021)

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
by: Hyung Kyu Park, et al.
Published: (2017)

Prognostic role of epidermal growth factor receptors' expression in patients with i-ii stage of non-small cell lung cancer
by: A.P. Kolesnik, et al.
Published: (2013)

Six cases of purpuric eruptions induced by epidermal growth factor receptor inhibitors
by: Tomoko Hiraiwa, et al.
Published: (2018)

Idiopathic extensive acanthosis nigricans with a variant of the epidermal growth factor receptor
by: Amena Alkeswani, BS, et al.
Published: (2020)

Dermatological side effects of epidermal growth factor receptor inhibitors: 'Pride' complex
by: Bhushan Madke, et al.
Published: (2014)